Logo FIGO 2018 | World Congress of Gynecology and Obstetrics
#FIGO2018 #EveryWomanMatters


The Scientific Programme Committee invites the submission of abstracts for scientific presentations at the most important international academic event in our specialty, the XXII FIGO World Congress.


Submission format

  • Abstracts are limited to 2.500 characters (including spaces).
  • Each application should specify whether it is for an oral or a poster presentation.
  • Oral presentations will be allocated 7 minutes for the presentation with an additional 3 minutes for questions and audience interaction.
  • Poster presentations will be in the format and size that will be conveyed after acceptance.
  • The Scientific Programme Committee may reassign submitted presentations between the two formats as per its discretion.

Submission limit

  • Only one presentation will be permitted to one designated presenter.
  • There are no restrictions on the number of abstracts submitted
  • Abstracts submitted to other international meetings must not be submitted and will not be accepted.

Presenting delegate

  • The presenting author must be a registered congress delegate.
  • Only the name of the presenting author will appear in the final congress programme.
  • Presenters whose abstracts have been accepted must register for the Congress and pay the registration fee before the registration deadline.
  • Failure to register in time may result in exclusion from the programme.

Language of submission

  • All abstracts must be submitted and presented in English.

Category of submission

  • The submission category for the abstract should be as per the official listing.
  • The one category considered most suitable for the oral or poster presentation should be selected.

Acceptance notification

  • Presenters will be notified regarding acceptation of their abstracts by April 30, 2018.
  • Presenters whose abstracts have been accepted must register for the Congress and pay the registration fee before May 15, 2018.
  • Failure to register in time may result in exclusion from the programme.
  • Further details and instructions for oral and poster presentation would be conveyed after that time.


Online abstract form is divided into the following sections


  • Concise statement on why the study was conducted.


  • Location, number and type of human subjects, non-human species or material being studied.
  • Design of the study and type of intervention.
  • Principal assays or test(s) performed and the types of statistical analyses if appropriate.


  • Main findings and results should be reported.
  • Results should be supported by statistical analysis where appropriate


  • Main conclusions of the study and significance of the results.
  • How the results may affect patient management or understanding of the condition.

Important caveats

  • Proof read abstract carefully before submitting.
  • Only use standard abbreviations if indicated.
  • Abstracts stating merely that the results will be presented or discussed at the congress may be rejected.
  • The use of tables and images in the abstract is not allowed.
  • Submissions by email, fax and post will not be accepted.
  • If you experience any technical difficulties, please email: abstractbrasil@mci-group.com


Submission deadline – March 15, 2018
Notification deadline – April 30, 2018
Registration deadline for presenters – May 15, 2018

For a better system performance, please, use the Firefox or Chrome Browser.


Please select the one that is most suitable for the presentation or poster submission:

AB 1 Maternal Fetal Health

  • AB 1.1 Prenatal Diagnosis
  • AB 1.2 Imaging in Obstetrics
  • AB 1.3 Assessment of Fetal Wellbeing
  • AB 1.4 Medical Disorders in Pregnancy
  • AB 1.5 High Risk Pregnancy

AB 2 Clinical Obstetrics

  • AB 2.1 Antenatal and Postnatal Care
  • AB 2.2 Labor and Delivery
  • AB 2.3 Operative Obstetrics
  • AB 2.4 Infections in Obstetrics
  • AB 2.5 Midwifery Care
  • AB 2.6 Neonatal Care

AB 3 General Gynecology

  • AB 3.1 Pediatric and Adolescent Gynecology
  • AB 3.2 Gynecological Care for the Older Woman
  • AB 3.3 Imaging in Gynecology
  • AB 3.4 Benign Conditions in Gynecology
  • AB 3.5 Infections in Gynecology

AB 4 Operative Gynecology

  • AB 4.1 Conventional and Benign Gynecological Surgery
  • AB 4.2 Minimal Access Surgery including Robotic Surgery
  • AB 4.3 Innovations in Gynecological Surgery
  • AB 4.4 Safe Surgical Techniques and Practice

AB 5 Reproductive Medicine

  • AB 5.1 Reproductive Endocrinology
  • AB 5.2 Management of Subfertility
  • AB 5.3 Male Infertility
  • AB 5.4 Assisted Reproduction
  • AB 5.5 Disorders of Sexual Development

AB 6 Sexual and Reproductive Health and Rights

  • AB 6.1 Contraception and Family Planning
  • AB 6.2 Termination of Pregnancy
  • AB 6.3 Human Sexuality
  • AB 6.4 Sexual and Reproductive Rights
  • AB 6.5 Awareness and Counselling in Sexual and Reproductive Health

AB 7 Urogynaecology

  • AB 7.1 Preventive Urogynecology
  • AB 7.2 Genital Prolapse – Management and Surgery
  • AB 7.3 Incontinence – Management and Surgery
  • AB 7.4 Genital Trauma and Fistulae

AB 8 Gynecological Oncology

  • AB 8.1 Preventive Oncology
  • AB 8.2 Diagnosis and Management of Gynecological Malignancies

AB 9 Women’s Health Issues and Policy

  • AB 9.1 Addressing Maternal Mortality
  • AB 9.2 Sustainable Development Goals
  • AB 9.3 Medical Education and Training
  • AB 9.4 Information Technology in Women’s Health
  • AB 9.5 Ethics and Law in Women’s Health

AB 10 Special Topics

  • AB 10.1 Women and the Environment
  • AB 10.2 Addressing Stigma and Violence against Women
  • AB 10.3 Women’s Health in Situations of Conflict and Disaster
  • AB 10.4 Research Methodology, Conduct and Dissemination
  • AB 10.5 Evidence Based Medicine and Guidelines